Literature DB >> 25511705

Crystal structure of the polo-box domain of polo-like kinase 2.

Hong-Mei Shan1, Tao Wang2, Jun-Min Quan3.   

Abstract

Polo-like kinase 2 (PLK2) is a crucial regulator in cell cycle progression, DNA damage response, and neuronal activity. PLK2 is characterized by the conserved N-terminal kinase domain and the unique C-terminal polo-box domain (PBD). The PBD mediates diverse functions of PLK2 by binding phosphorylated Ser-pSer/pThr motifs of its substrates. Here, we report the first crystal structure of the PBD of PLK2. The overall structure of the PLK2 PBD is similar to that of the PLK1 PBD, which is composed by two polo boxes each contain β6α structures that form a 12-stranded β sandwich domain. The edge of the interface between the two polo boxes forms the phosphorylated Ser-pSer/pThr motifs binding cleft. On the hand, the peripheral regions around the core binding cleft of the PLK2 PBD is distinct from that of the PLK1 PBD, which might confer the substrate specificity of the PBDs of the polo-like kinase family.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell cycle; DNA damage; Neuronal activity; Polo-box domain; Polo-like kinase 2

Mesh:

Substances:

Year:  2014        PMID: 25511705     DOI: 10.1016/j.bbrc.2014.11.125

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Recent Advances and New Strategies in Targeting Plk1 for Anticancer Therapy.

Authors:  Kyung S Lee; Terrence R Burke; Jung-Eun Park; Jeong K Bang; Eunhye Lee
Journal:  Trends Pharmacol Sci       Date:  2015-10-17       Impact factor: 14.819

2.  Structural analysis of the polo-box domain of human Polo-like kinase 2.

Authors:  Ju Hee Kim; Bonsu Ku; Kyung S Lee; Seung Jun Kim
Journal:  Proteins       Date:  2015-04-28

3.  Enhancing polo-like kinase 1 selectivity of polo-box domain-binding peptides.

Authors:  Xue Zhi Zhao; David Hymel; Terrence R Burke
Journal:  Bioorg Med Chem       Date:  2017-02-28       Impact factor: 3.641

Review 4.  The role of Plk3 in oncogenesis.

Authors:  C Helmke; S Becker; K Strebhardt
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

5.  Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling.

Authors:  Elizabeth M Matthew; Zhaohai Yang; Suraj Peri; Mark Andrake; Roland Dunbrack; Eric Ross; Wafik S El-Deiry
Journal:  Neoplasia       Date:  2018-02-12       Impact factor: 5.715

Review 6.  Polo-Like Kinase 2: From Principle to Practice.

Authors:  Chuanyong Zhang; Chuangye Ni; Hao Lu
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.